October 12, 2005 Pfizer won a patent fight over the best selling drug in the world, Lilly and ICOS reported that Cialis treats symptoms of benign prostatic hyperplasia, Pozen earned a $20 million milestone from GlaxoSmithKline, Vical sold 4.7 million shares at a 20% discount (its shares dropped by a similar amount), and EntreMed announced anti-tumor activity in laboratory studies for an analogue of its lead drug candidate. Biotech moved lower again today, with the Centient Biotech 200 dropping 41 points to close at 3578.54, a loss of 1.13%. More details...
